| Active Not Recruiting | Effects of Kegel Ball and Pelvic Floor Exercises on Sexual Function, Unrınary Incontinence and Quality of Life NCT07048145 | sahra sultan kara | N/A |
| Completed | Sexual Health of Women With Genital Mutilation Seen at the Saint-Denis Women's Center NCT07027696 | Centre Hospitalier de Saint-Denis | — |
| Recruiting | Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disea NCT05777031 | University of Miami | Phase 4 |
| Unknown | Quality of Sexual Function in BRCA Mutated Women NCT05456919 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | — |
| Recruiting | Early Psychological Intervention After Rape NCT05489133 | St. Olavs Hospital | N/A |
| Completed | Internet-based Emotion Regulation Intervention for Sexual Health NCT04792177 | University of Luxembourg | N/A |
| Completed | Sexual Function Changes in High-Risk Pregnancies NCT05093647 | Saglik Bilimleri Universitesi | — |
| Unknown | Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD). NCT04433559 | Lidia Larrañaga | Phase 3 |
| Completed | Mindfulness as Treatment of Sexological Problems NCT03775239 | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | N/A |
| Completed | Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT NCT03365518 | University of British Columbia | N/A |
| Completed | Consistency of Questionnaires to Evaluating Sexual Functions in Young Healthy Women NCT03241524 | Universidade Federal do Rio Grande do Norte | N/A |
| Completed | Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men NCT02593396 | University of Malaya | Phase 2 |
| Completed | Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer NCT02381912 | Herlev Hospital | — |
| Completed | A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer NCT01654458 | Women's College Hospital | N/A |
| Completed | Sexual Health on Antidepressants Through Physical Exercise NCT01188720 | University of Texas at Austin | N/A |
| Completed | Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) NCT01188603 | Sprout Pharmaceuticals, Inc | Phase 1 |
| Terminated | A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder NCT01103362 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Terminated | Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America NCT01057901 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Terminated | 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and NCT01040208 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Diso NCT00996164 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women NCT00996372 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder NCT00601367 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | HIV Prevention Among Vulnerable Male Youth NCT01771237 | Ann & Robert H Lurie Children's Hospital of Chicago | N/A |
| Completed | Flibanserin Versus Placebo in Premenopausal Women With HSDD NCT00491829 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Terminated | A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (H NCT00441558 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA NCT00360243 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desir NCT00360529 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder NCT00360555 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women NCT00277914 | Sprout Pharmaceuticals, Inc | Phase 3 |
| Completed | Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties NCT00175539 | University of British Columbia | N/A |
| Completed | Cervical or Endometrial Cancer and Sexual Health Study NCT00134316 | University of British Columbia | N/A |
| Completed | Female Sexual Dysfunction: Prevalence Among Italian Healthy Women NCT00148200 | Unita Complessa di Ostetricia e Ginecologia | — |
| Completed | An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sex NCT00746967 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 2 |
| Completed | Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction NCT00034021 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |